Ind Swift Laboratories Share Price
Ind Swift Laboratories Share Price Today
As of 5 Jul 2026, Ind Swift Laboratories share price is ₹214.16. The stock opened at ₹206.91, compared to its previous close of ₹206.22. During today's trading session, Ind Swift Laboratories share price moved in the range of ₹206.86 to ₹216.83, with an average price of ₹211.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹87.15 and a high of ₹216.83. On the performance front, Ind Swift Laboratories share price has increased by 133.93% over the last six months and is up 86.89% on a year-on-year basis.
Ind Swift Laboratories Returns Calculator
Ind Swift Laboratories Shareholder Returns
Ind Swift Laboratories Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Ind Swift Laboratories Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹561.71 | ₹1,280.90 | ₹1,207.31 | ₹1,038.73 |
| Other Income | ₹81.38 | ₹45.37 | ₹33.50 | ₹43.50 |
| Total Revenue | ₹643.09 | ₹1,326.27 | ₹1,240.81 | ₹1,082.23 |
| Total Expenses | ₹608.50 | ₹1,131.10 | ₹1,127.64 | ₹1,069.70 |
| Profit Before Tax | ₹257.80 | ₹581.76 | ₹86.52 | ₹12.53 |
| Tax | ₹7.27 | ₹160.31 | ₹38.69 | ₹14.68 |
| Profit After Tax | ₹250.53 | ₹421.45 | ₹47.83 | -₹2.15 |
| EPS - Basic | ₹37.25 | ₹71.24 | ₹8.10 | -₹0.36 |
| EPS - Diluted | ₹35.21 | ₹71.24 | ₹8.10 | -₹0.36 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹34.59 | ₹195.17 | ₹113.17 | ₹12.53 |
| Income before WC changes | -₹5.72 | ₹319.93 | ₹245.95 | ₹238.19 |
| Change in Assets | ₹47.29 | -₹515.89 | -₹68.39 | -₹119.60 |
| Change in Liabilities | -₹67.05 | ₹32.84 | ₹17.07 | ₹31.68 |
| Change in WC | -₹19.76 | -₹483.05 | -₹51.33 | -₹87.92 |
| Cash flow from Operations | -₹25.47 | -₹163.12 | ₹194.62 | ₹150.27 |
| Cash flow from Investing | -₹109.62 | -₹104.32 | -₹13.37 | ₹4.77 |
| Cash flow from Financing | ₹69.20 | ₹698.91 | -₹185.66 | -₹140.88 |
| Total Cash Flow | -₹65.89 | ₹431.48 | -₹4.41 | ₹14.17 |
| Cash (Start of the year) | ₹493.93 | ₹18.20 | ₹21.48 | ₹11.60 |
| Cash (End of the year) | ₹427.46 | ₹449.68 | ₹17.07 | ₹25.77 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹572.99 | ₹503.98 | ₹659.55 | ₹725.46 |
| Current Assets | ₹865.35 | ₹661.13 | ₹1,164.52 | ₹1,075.33 |
| Total Assets | ₹1,438.34 | ₹1,165.11 | ₹1,824.06 | ₹1,800.79 |
| Current Liabilities | ₹220.58 | ₹221.28 | ₹371.09 | ₹334.47 |
| Net Current Asset | ₹644.77 | ₹439.85 | ₹793.43 | ₹740.87 |
| Non-Current Liabilities | ₹44.79 | ₹12.39 | ₹771.04 | ₹865.47 |
| Equity Capital | ₹1,172.96 | ₹931.44 | ₹681.93 | ₹600.86 |
| Total Equity & Liabilities | ₹1,438.34 | ₹1,165.11 | ₹1,824.06 | ₹1,800.79 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹549.65 | ₹1,227.32 | ₹1,151.96 | ₹988.09 |
| Other Income | ₹81.27 | ₹45.31 | ₹33.28 | ₹42.50 |
| Total Revenue | ₹630.92 | ₹1,272.63 | ₹1,185.24 | ₹1,030.59 |
| Total Expenses | ₹589.98 | ₹1,081.75 | ₹1,079.39 | ₹1,020.90 |
| Profit Before Tax | ₹264.14 | ₹577.47 | ₹79.20 | ₹8.00 |
| Tax | ₹8.06 | ₹159.08 | ₹36.73 | ₹13.70 |
| Profit After Tax | ₹256.09 | ₹418.39 | ₹42.47 | -₹5.71 |
| EPS - Basic | ₹38.08 | ₹70.81 | ₹7.19 | -₹0.97 |
| EPS - Diluted | ₹36.00 | ₹70.81 | ₹7.19 | -₹0.97 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹40.94 | ₹190.88 | ₹105.85 | ₹9.69 |
| Income before WC changes | ₹0.67 | ₹315.64 | ₹238.62 | ₹235.28 |
| Change in Assets | -₹4.90 | -₹507.54 | -₹73.90 | -₹134.77 |
| Change in Liabilities | -₹34.93 | ₹12.13 | ₹17.95 | ₹35.75 |
| Change in WC | -₹39.83 | -₹495.41 | -₹55.95 | -₹99.02 |
| Cash flow from Operations | -₹39.15 | -₹179.77 | ₹182.67 | ₹136.26 |
| Cash flow from Investing | -₹109.67 | -₹104.32 | -₹13.69 | ₹2.76 |
| Cash flow from Financing | ₹74.22 | ₹699.86 | -₹168.41 | -₹139.59 |
| Total Cash Flow | -₹74.60 | ₹415.77 | ₹0.58 | -₹0.57 |
| Cash (Start of the year) | ₹487.62 | ₹9.96 | ₹9.38 | ₹9.95 |
| Cash (End of the year) | ₹413.01 | ₹425.73 | ₹9.96 | ₹9.38 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹628.32 | ₹559.25 | ₹714.20 | ₹804.75 |
| Current Assets | ₹793.73 | ₹545.54 | ₹1,074.07 | ₹998.16 |
| Total Assets | ₹1,422.05 | ₹1,104.79 | ₹1,788.27 | ₹1,802.91 |
| Current Liabilities | ₹216.35 | ₹178.32 | ₹350.05 | ₹313.61 |
| Net Current Asset | ₹577.38 | ₹367.22 | ₹724.02 | ₹684.55 |
| Non-Current Liabilities | ₹41.63 | ₹4.22 | ₹762.88 | ₹856.75 |
| Equity Capital | ₹1,164.08 | ₹922.24 | ₹675.35 | ₹632.56 |
| Total Equity & Liabilities | ₹1,422.05 | ₹1,104.79 | ₹1,788.27 | ₹1,802.91 |
About Ind Swift Laboratories
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Ind Swift Laboratories Financial Highlights
- Revenue: Ind Swift Laboratories reported revenue of ₹688.26 crore in FY26 vs ₹643.09 crore in FY25. It showed an increase of 7.02% on a yearly basis.
- Operating Profit: Ind Swift Laboratories reported an operating profit of ₹49.05 crore in FY26 vs ₹257.80 crore in FY25. It showed a decrease of 80.97% on a year-on-year basis.
- Net Profit: Ind Swift Laboratories reported a net profit of ₹41.32 crore in FY26 vs ₹250.53 crore in FY25. It showed a decrease of 83.51% on a yearly basis.
Ind Swift Laboratories Quarterly Result Highlights
- Ind Swift Laboratories reported revenue of ₹172.01 crore in Mar 2026, compared with ₹178.43 crore in Dec 2025, representing a decrease of 3.60% on a quarter-on-quarter (QoQ) basis.
- Ind Swift Laboratories reported an operating profit of ₹11.96 crore in Mar 2026, compared with ₹16.39 crore in Dec 2025, representing a decrease of 27.03% on a quarter-on-quarter (QoQ) basis.
- Ind Swift Laboratories reported a profit of ₹15.11 crore in Mar 2026, compared with ₹9.52 crore in Dec 2025, reflecting an increase of 58.72% on a QoQ basis.
- The earnings per share (EPS) of Ind Swift Laboratories stood at ₹37.25 during Mar 2026.
Similar Stocks
FAQs on Ind Swift Laboratories Share Price
What is Ind Swift Laboratories share price today?
Ind Swift Laboratories share price is ₹214.16 as on 03 Jul, 2026, 15:44 IST.
How has the Ind Swift Laboratories share price performed in the past?
In the last 1 year, Ind Swift Laboratories delivered a return of 86.89%. The Ind Swift Laboratories share price hit a high of ₹216.83 and low of ₹87.15.
How much is the Mutual Fund shareholding in Ind Swift Laboratories shares?
The Mutual Fund Shareholding in Ind Swift Laboratories was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Ind Swift Laboratories shares ?
The 52-week high and low of Ind Swift Laboratories share is ₹216.83 and ₹87.15 as of 03 Jul, 2026.
What is the market cap of Ind Swift Laboratories?
The market capitalisation of Ind Swift Laboratories is ₹1,793.15 Crores as on 03 Jul, 2026.
What are the stock symbols of Ind Swift Laboratories?
The stock symbol of Ind Swift Laboratories is INDSWFTLAB on the NSE, 532305 on the BSE, and the ISIN is INE915B01019.
What was yesterday's closing price of Ind Swift Laboratories shares ?
Ind Swift Laboratories shares closed yesterday at ₹206.22 on NSE & ₹206.20 on BSE
How to buy Ind Swift Laboratories shares?
To buy Ind Swift Laboratories shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Ind Swift Laboratories shares on Holidays?
No, shares of Ind Swift Laboratories or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Ind Swift Laboratories shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Ind Swift Laboratories?
The PE and PB ratio of Ind Swift Laboratories is 43.32 and 1.3 respectively, as on 03 Jul, 2026, 15:44 IST.